Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Advocate knocks mayor for Troost renaming delay; calls slave owner tie KC’s ‘dirty laundry, reeking from the basement’
Kansas City can no longer whitewash its history to pretend Benoist Troost — an early KC doctor, slave owner and the namesake for Troost Avenue — was anything other than a monster, said Chris Goode, pointing blame at Mayor Quinton Lucas for a stalled effort to change the east side corridor’s controversial name. “There’s no…
C3KC organizers: Want to bring real social change to Kansas City? Let’s talk about it
The sold-out C3KC — a one-day conference that returns Tuesday, April 2 to Union Station — reflects the Junior League of Kansas City’s mission to bring together leaders for collaborative change in action, shared Ericka Duker. The Junior League — which aims to advance women’s leadership for meaningful community impact through volunteer action, collaboration and…
Passing the keys, passion: How a new wave of small biz owners plan to preserve beloved local brands
Some have been customers; some employees. Now they’re the new owners of popular local restaurants and retail shops. As founders step aside, fresh sets of entrepreneurs step up in hopes of carrying on the goodwill and loyal following these brands have built up, some for decades. John McClelland and his brother-in-law, Johnathan Griffiths, work together…
Topping expectations: These brothers helped expand Pizza Tascio to 8 locations; now they’re taking over
Erik Borger hired all three Lombardino brothers in their teens, starting them out as dishwashers at his restaurants in St. Joseph, Missouri. They quickly took on other positions — front of house, staff scheduling, food and beverage orders and deliveries, and hiring and firing workers. If an employee didn’t show up for a shift, they…